Rating Change
Barclays analysts initiated coverage on Boston Scientific Corporation (NYSE:BSX) with a rating of Equal-Weight on October 07, 2026.
new coverageNYSE:BSX
Barclays Initiates Coverage on Boston Scientific Corporation (BSX) with Equal-Weight
Barclays analysts initiated coverage on Boston Scientific Corporation (NYSE:BSX) with a rating of Equal-Weight on October 07, 2026.
At publication ·
What changed
Boston Scientific Corporation (NYSE:BSX) · new coverage
- Firm
- Barclays
- Rating
- Equal-Weight
- Price at event
- $41.58
- Market capitalization
- $136.0B
At a glance
Key takeaways
- Barclays initiated coverage of Boston Scientific (BSX) with an Equal-Weight rating on October 7, 2026.
- BSX stock trades at $41.58 with a $136.0B market cap and has declined 56.2% over the past 52 weeks.
Market Context
Boston Scientific Corporation operates in the Healthcare sector. The stock currently trades at $41.58 with a market capitalization of $136.0B. The stock has declined 56.2% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Boston Scientific Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Boston Scientific Corporation
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 07, 2026 | Barclays | Equal-Weight | N/A |
| Oct 05, 2026 | Citigroup | Neutral | N/A |
| Sep 24, 2026 | Wells Fargo | Equal-Weight | N/A |
| Sep 21, 2026 | Oppenheimer | Outperform | N/A |
| Sep 17, 2026 | Citigroup | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View BSX Stock Page
Frequently Asked Questions
What does the Equal-Weight rating mean for BSX?
A rating of Equal-Weight from Barclays reflects the analyst's outlook on Boston Scientific Corporation (NYSE:BSX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BSX forecast page.
